Announcements & Press Releases

Accelerate Diagnostics, Inc. (AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections,...

Accelerate Diagnostics, Inc. (AXDX), today announced that it has appointed Pete Bantock to the position of Chief Commercial Officer, effective today. Most recently Pete was Sr. Vice President and...

Accelerate Diagnostics, Inc. (AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections, today...

Educating your customers and prospects by sharing expertise and insight is at the heart of content marketing. According to a recent article by Joe Pulizzi,...

Accelerate Diagnostics Announces Plans For Rights Offering To StockholdersTUCSON, Ariz., June 4, 2013 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX), an in vitro diagnostics company dedicated...

Accelerate Diagnostics, Inc. Names Frank J. M. ten Brink to Board of DirectorsTUCSON, Ariz., March 6, 2013 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX), a developer of automated diagnostic...

Accelr8 Technology Corporation (NYSE MKT: AXK) announced today that its common stock has been approved by The NASDAQ Stock Market, LLC for listing on the NASDAQ Capital Market. The Company expects...

Accelr8 Closes on InvestmentDenver, Co., June 26, 2012 – Accelr8 Technology Corporation (NYSE MKT: AXK) announced today that it has received shareholder approval, met all closing conditions, and...

Denver, Co., June 22, 2012 – Accelr8 Technology Corporation (NYSE MKT: AXK) announced results of two studies that it presented at the 112th annual General Meeting of the American Society for...

Accelr8 and Denver Health Notified by Department of Defense for Rapid Diagnostics AwardDENVER, Colo., May 15, 2012 – Accelr8 Technology Corporation (NYSE MKT: AXK) and Denver Health received...